Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives
- PMID: 18497518
- DOI: 10.1159/000122590
Mitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives
Abstract
Mitomycin C (MMC) is among the most effective anticancer drugs used for the treatment of a broad variety of tumours. This review summarises results of MMC-based chemotherapy in gastrointestinal tumours with special focus on current treatment options in gastric, pancreatic, biliary tract, colorectal, and anal cancer. In addition, these new developments are critically discussed with special attention to their potential clinical relevance.
(c) 2008 S. Karger AG, Basel
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources